back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-10 17:44 Tx date 2024-04-05 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
57 - Exercise of rights
|
+60,000 vol |
142,500 | |
| Filed 2024-04-10 17:43 Tx date 2024-04-05 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-60,000 vol |
0 | |
| Filed 2022-10-05 17:54 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-244,800
-60,000 vol $4.08 each |
0 | |
| Filed 2022-10-05 17:53 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$84,600
+60,000 vol $1.41 each |
60,000 | |
| Filed 2022-10-05 17:51 Tx date 2019-12-03 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-26 17:44 Tx date 2021-02-25 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$99,450
+22,500 vol $4.42 each |
82,500 | |
| Filed 2021-02-26 17:41 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$65,000
+20,000 vol $3.25 each |
60,000 | |
| Filed 2021-02-26 17:37 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-65,000
-20,000 vol $3.25 each |
0 | |
| Filed 2020-06-05 17:16 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$4,400
+20,000 vol $0.22 each |
20,000 | |
| Filed 2020-06-05 17:10 Tx date 2019-12-03 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-05 17:09 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
15 - Acquisition or disposition under a prospectus
|
$95,600
+40,000 vol $2.39 each |
40,000 | |
| Filed 2020-06-05 17:08 Tx date 2019-12-03 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-12-09 12:11 Tx date 2019-12-03 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$244,800
+60,000 vol $4.08 each |
60,000 | |
| Filed 2019-12-09 12:07 Tx date 2019-12-03 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|